The American Journal of Managed Care1h
Adaptive Deep Brain Stimulation Technology Receives FDA Approval for Parkinson Disease
The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...
InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...
PharmiWeb13h
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global ...